HomeNewsBusinessPetrol dealers' association asks members to defer protests after meeting petroleum ministry officials

Petrol dealers' association asks members to defer protests after meeting petroleum ministry officials

AIPDA, which represents 22 state fuel dealers associations in India, met petroleum ministry officials, who assured them that their demand will be fast-tracked and that the centre will set up a meeting between fuel dealers and oil marketing companies.

May 27, 2022 / 15:42 IST
Story continues below Advertisement
Representational image
Representational image

The All India Petrol Pump Dealers Association (AIPDA) on May 27 said that it has asked its members to not shut down their petrol pumps as a form of protest after their meeting with petroleum ministry officials.

Dealers' associations from Telangana, Rajasthan, Andhra Pradesh, Maharashtra, Himachal Pradesh, Delhi, Bihar, Tamil Nadu, parts of Kerala and West Bengal had said that they will observe a ‘no purchase of fuel’ day, as part of their protest against short supply of fuel and reduced excise duty by the central government.

Story continues below Advertisement

AIPDA, which represents 22 state fuel dealers associations in India, at a press conference on May 27 said that they have met officials from the petroleum ministry, who have assured them that their demand will be fast-tracked and that the centre will set up a meeting between fuel dealers and oil marketing companies.

"Oil companies should raise dealers' commission on the sale of petrol and diesel to 5 percent of retail price as operating costs have risen," said AIPDA President Ajay Bansal.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show